Sign in

CIK 0001425205

  • Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
753254381
Phone
+1 650-260-7120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
  1. 4 Open-market buy Director bought 10,000,000 shares at $6.50 ($65,000,000)
  2. 4 Open-market buy Director bought 10,000 shares at $6.31 ($63,100)
  3. 4 Open-market buy Interim CEO & General Counsel bought 1,000 shares at $5.98 ($5,980)
  4. 4 Open-market buy Director bought 10,000 shares at $6.18 ($61,800)
  5. 4 Open-market buy Director bought 10,000 shares at $6.10 ($61,000)
  6. 4 Option exercise Director acquired 40,000 shares (option exercise)
  7. 4 Shares withheld for taxes Chief Medical Officer gave up 6,809 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Financial Officer gave up 9,346 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Operating Officer gave up 9,346 shares (to pay taxes)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Director bought 20,000 shares at an average $6.82 ($136,400)
  18. 4 Open-market buy Director bought 7,500 shares at $6.75 ($50,588)
  19. 4 Open-market buy Director bought 10,000 shares at an average $6.80 ($67,978)
  20. 4 Open-market buy Interim CEO & General Counsel bought 1,000 shares at $6.44 ($6,440)

Page 9 of 18 · 352 filings